Jun Nagai Selected Research

Therapeutics

6/2023	Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone.
10/2021	Patients with marginal zone dural lymphoma successfully treated with rituximab and bendamustine: A report of two cases.
1/2019	[Aplastic anemia following drug-induced liver injury].
1/2019	Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis.
3/2014	[Small cell carcinoma in a vesical diverticulum: a case report].
7/2008	[Idiopathic retroperitoneal fibrosis diagnosed by CT-guided needle biopsy: a case report].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Nagai Research Topics

Disease

11	Neuralgia (Stump Neuralgia) 11/2018 - 11/2009
10	Inflammation (Inflammations) 02/2024 - 05/2010
5	Hyperalgesia 01/2021 - 05/2010
5	Neoplasms (Cancer) 01/2020 - 08/2013
5	Spinal Cord Injuries (Spinal Cord Injury) 11/2018 - 01/2012
4	Pain (Aches) 01/2013 - 12/2010
3	Parkinson Disease (Parkinson's Disease) 09/2023 - 01/2016
3	Chronic Pain 01/2021 - 05/2011
3	Infections 01/2020 - 12/2013
3	Cicatrix (Scar) 01/2017 - 02/2015
2	Asthma (Bronchial Asthma) 12/2023 - 12/2019
2	Vasculitis (Vasculitides) 06/2023 - 01/2019
2	Pneumonia (Pneumonitis) 12/2022 - 12/2019
2	Huntington Disease (Huntington's Disease) 12/2020 - 01/2018
2	Optic Nerve Injuries 10/2019 - 01/2019
2	Wounds and Injuries (Trauma) 03/2016 - 01/2016
2	Fibromyalgia (Fibrositis) 09/2011 - 03/2010
2	Demyelinating Diseases (Demyelinating Disease) 11/2010 - 05/2010
1	Down Syndrome (Down's Syndrome) 02/2024
1	Respiratory Hypersensitivity 12/2023
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Obesity 12/2023
1	Monoclonal Gammopathy of Undetermined Significance 06/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2022
1	Evans Syndrome 03/2022
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2022
1	COVID-19 03/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022
1	Seizures (Absence Seizure) 01/2022
1	Protozoan Infections 01/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2021
1	Lymphoma (Lymphomas) 10/2021
1	Rare Diseases (Rare Disease) 10/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Allergic Rhinitis 12/2019
1	Wallerian Degeneration 01/2019

Drug/Important Bio-Agent (IBA)

12	lysophosphatidic acidIBA 01/2021 - 11/2009
4	Lysophosphatidic Acid ReceptorsIBA 01/2019 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2010
3	SteroidsIBA 06/2023 - 07/2008
3	Semaphorin-3AIBA 01/2019 - 02/2015
2	Phospholipases A2 (Phospholipase A2)IBA 02/2024 - 05/2010
2	Interleukin-33IBA 12/2023 - 01/2021
2	CalciumIBA 01/2023 - 11/2010
2	purinoceptor P2Y6IBA 12/2022 - 12/2019
2	Uridine Diphosphate (UDP)IBA 12/2022 - 12/2019
2	EnzymesIBA 01/2022 - 11/2010
2	Chemotactic FactorsIBA 01/2021 - 01/2019
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2020 - 08/2013
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020 - 01/2016
2	lanthionine ketimineIBA 01/2020 - 01/2017
2	EstersIBA 01/2020 - 01/2017
2	LipidsIBA 01/2019 - 08/2013
2	Myelin-Associated GlycoproteinIBA 11/2010 - 05/2010
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2010 - 11/2009
1	Nonesterified Fatty Acids (NEFA)IBA 02/2024
1	Linoleic Acid (Linoleate)IBA 02/2024
1	Cell Adhesion MoleculesIBA 02/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023
1	Liraglutide FDA Link 12/2023
1	CopperIBA 09/2023
1	CryoglobulinsIBA 06/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2023
1	Bortezomib (Velcade)FDA Link 06/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	Interleukin-12 (IL 12)IBA 12/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	Inosine Triphosphate (ITP)IBA 03/2022
1	BNT162 VaccineIBA 03/2022
1	MagnesiumIBA 01/2022
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2022
1	Rituximab (Mabthera)FDA Link 10/2021
1	Bendamustine Hydrochloride FDA Link 10/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	AllergensIBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021
1	OvalbuminIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	Leukotriene C4IBA 01/2021
1	Leukotriene D4IBA 01/2021
1	Interleukin-13IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	LeukotrienesIBA 12/2019
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 12/2019
1	Interleukin-12 Subunit p40IBA 12/2019
1	CytokinesIBA 12/2019
1	Serine (L-Serine)FDA Link 10/2019
1	Nonprescription Drugs (Patent Medicines)IBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2019

Therapy/Procedure

7	Spinal Injections 01/2021 - 11/2009
6	Therapeutics 06/2023 - 07/2008
3	Ligation 01/2021 - 12/2010
2	Immunotherapy 01/2020 - 01/2019
1	Radiotherapy 10/2021